How likely is flu-related pneumonia to happen to you? What are the symptoms to look out for when they can be similar to those ...
Dr. Peter Daley, an associate professor of infectious disease at Memorial University, says the testing is taking place at the Mundy Pond clinic. They will give the patient a nose swab and, within 30 ...
Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.
You probably think “antibiotic resistance” means that a bacterial infection can’t be cured by any antibiotics. But the FDA ...
The intravenous antibiotic Emblaveo, a combination of aztreonam and avibactam approved in Europe last year, was developed in ...
The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.
An expert briefly describes the study ‘Single Dose Aminoglycosides versus Carbapenems for the Treatment of Uncomplicated ...
An expert briefly describes the study ‘Single Dose Aminoglycosides versus Carbapenems for the Treatment of Uncomplicated Urinary Tract Infections Caused by Extended-Spectrum β-lactamase-phenotype Gram ...
GlobalData on MSN16h
FDA approves AbbVie’s Emblaveo for intra-abdominal infectionsAbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback